Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Lung Cancer. 2018 Feb 4;117:73–79. doi: 10.1016/j.lungcan.2018.01.022

Table 2.

Associations (correlation coefficients) of G-cross scores with tumor pathologic factors

Tumor pathologic variables
G-Cross AUC Variables Tumor
histology		 Tumor
differentiati on		 Tumor
size		 Number of
positive
lymph
nodes		 Pathologic
tumor
stage		 Perineural
invasion		 LVSI ECE
Tumor: CD8 0.544
(P=0.91)		 6.804
(P=0.10)		 −0.057
(P=0.84)		 −0.090
(P=0.69)		 1.652
(P=1.0)		 0.141
(P=0.95)		 1.627
(P=0.45)		 0.290
(P=0.91)
Tumor: CD68 2.826
(P=0.81)		 2.608
(P=0.28)		 −0.137
(P=0.49)		 0.033
(P=0.89)		 4.841
(P=1.0)		 0.081
(P=0.95)		 4.335
(P=0.25)		 0.790
(P=0.91)
Tumor: CD4 0.958
(P=0.91)		 1.421
(P=0.45)		 −0.051
(P=0.86)		 0.008
(P=0.95)		 1.795
(P=1.0)		 1.077
(P=0.95)		 0.370
(P=0.76)		 1.104
(P=0.91)
Tumor: FoxP3 2.239
(P=0.88)		 2.486
(P=0.28)		 0.027
(P=0.92)		 −0.086
(P=0.69)		 8.219
(P=0.67)		 0.014
(P=0.97)		 0.177
(P=0.76)		 0.122
(P=0.91)
Tumor: CD8 + CD68 2.283
(P=0.88)		 4.776
(P=0.16)		 −0.066
(P=0.82)		 −0.007
(P=0.95)		 2.727
(P=1.0)		 0.190
(P=0.95)		 7.005
(P=0.07)		 2.116
(P=0.89)
Tumor: CD8 + CD4 0.863
(P=0.91)		 5.900
(P=0.10)		 −0.046
(P=0.86)		 −0.036
(P=0.89)		 2.017
(P=1.0)		 0.418
(P=0.95)		 2.461
(P=0.39)		 0.132
(P=0.91)
Tumor: CD8 + FoxP3 0.827
(P=0.91)		 6.409
(P=0.10)		 −0.033
(P=0.92)		 −0.086
(P=0.69)		 1.425
(P=1.0)		 0.032
(P=0.96)		 1.517
(P=0.45)		 0.197
(P=0.91)
Tumor: CD68 + CD4 1.303
(P=0.91)		 2.191
(P=0.31)		 −0.094
(P=0.71)		 0.043
(P=0.90)		 3.284
(P=1.0)		 0.684
(P=0.95)		 2.893
(P=0.37)		 0.040
(P=0.91)
Tumor: CD68 + FoxP3 1.116
(P=0.91)		 4.206
(P=0.18)		 −0.081
(P=0.74)		 0.009
(P=0.95)		 3.020
(P=1.0)		 0.044
(P=0.96)		 3.386
(P=0.35)		 0.675
(P=0.91)
Tumor: CD4 + Foxp3 1.815
(P=0.91)		 3.407
(P=0.22)		 −0.018
(P=0.92)		 −0.011
(P=0.95)		 2.509
(P=1.0)		 0.380
(P=0.95)		 0.270
(P=0.76)		 0.490
(P=0.91)
FoxP3: CD8 11.396
(P=0.09)		 0.0003
(P=1.0)		 0.140
(P=0.49)		 −0.041
(P=0.90)		 10.700
(P=0.33)		 0.190
(P=0.95)		 0.286
(P=0.76)		 0.197
(P=0.91)
*

None of the above correlations reached statistical significance, adjusted P < 0.05.

Abbreviations: KPS = Karnofsky performance status, LVSI = lymphovascular space invasion.